Thrilled to share our highlights from the 2026 XDC & Antibody Drug Innovation Summit!
The 2026 XDC & Antibody Drug Innovation Summit concluded successfully from January 6 to 7 at the DoubleTree by Hilton Hangzhou East Lake.
As a trusted biologics CDMO, we showcased our next-gen ADC conjugation core technologies and one-stop platform solutions. Dr. Peng Qiang, Director of ADC Conjugation Process Development, delivered a standout keynote titled 《Accelerating Conjugation Process Development for Next-Generation ADCs: Key Considerations and Platform Strategies》—diving into random/site-specific conjugation, process challenges, and scalable industrialization insights, backed by 10+ years of experience across 30+ global bioconjugate projects.
Great connections with industry innovators, exploring ADC development trends and collaboration opportunities!
📩: MKT@asymchem.com.cn
